Zhangzhou Pientzehuang Pharmaceutical., Ltd

Shanghai Stock Exchange 600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd Price to Book Ratio (P/B) on January 14, 2025: 9.05

Zhangzhou Pientzehuang Pharmaceutical., Ltd Price to Book Ratio (P/B) is 9.05 on January 14, 2025, a -7.45% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.

Zhangzhou Pientzehuang Pharmaceutical., Ltd 52-week high Price to Book Ratio (P/B) is 12.37 on October 08, 2024, which is 36.76% above the current Price to Book Ratio (P/B).
Zhangzhou Pientzehuang Pharmaceutical., Ltd 52-week low Price to Book Ratio (P/B) is 8.39 on February 02, 2024, which is -7.24% below the current Price to Book Ratio (P/B).
Zhangzhou Pientzehuang Pharmaceutical., Ltd average Price to Book Ratio (P/B) for the last 52 weeks is 9.88.

Key data

Date	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield	Price to Earnings Ratio (P/E)

Shanghai Stock Exchange: 600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd

CEO	Mr. Jin Ming Huang
IPO Date	June 16, 2003
Location	China
Headquarters	Pien Tze Huang Building
Employees	2,789
Sector	Health Care
Industries Pharmaceuticals Cosmetics Drugstores & Retail Pharmacies

Description

Zhangzhou Pientzehuang Pharmaceutical., Ltd engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally. The company's products include medicines and health products, cosmetics, daily chemicals, medical apparatus and instruments, and health foods. The company is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical., Ltd is a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.

Key trends

Past 5 years